The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Epidemiology And Prevention Of Viral Hepatitis-related Hepatocellular Carcinoma
Funder
National Health and Medical Research Council
Funding Amount
$532,507.00
Summary
Liver cancer (HCC) is a serious global issue with high mortality. Viral hepatitis is a major risk and HCC can be prevented by early detection and treatment of hepatitis B infection. The PROLIFICA study aims to identify risks for HCC in West Africa, evaluate prevention strategies and develop simple diagnostic tests to help with HCC management in resource-poor settings. This important research will be directly translatable for HCC prevention in Australia and the Asia-Pacific region.
Improving Outcomes From Hepatitis B Infection In Aboriginal And Torres Strait Islander People In Northern Australia
Funder
National Health and Medical Research Council
Funding Amount
$189,384.00
Summary
Hepatitis B infection is common in Indigenous Australians causing serious problems such as liver failure and liver cancer. In the NT, there is an unusual and aggressive type. This project will establish if this unique strain does cause more liver failure and liver cancer. I will develop a special urine test to enable checking for liver cancer, and assess whether the use of the "Hep B Story" App will help people to have a better understanding of hepatitis B.
Population-level Epidemiological Trends In Hepatocellular Carcinoma In Queensland 1996 - 2010.
Funder
National Health and Medical Research Council
Funding Amount
$251,695.00
Summary
Incidence and mortality of hepatocellular carcinoma (HCC, the most common form of liver cancer) is increasing in Australia, driven by viral hepatitis infections. Disease burden is not defined in Queensland, particularly for Indigenous, migrant and regional and remote communities. Such factors may influence risk of viral hepatitis, access to treatment, and incidence and survival of HCC. Defining disease burdens will enable clinical programs targeted at groups most at risk in order to impact HCC t ....Incidence and mortality of hepatocellular carcinoma (HCC, the most common form of liver cancer) is increasing in Australia, driven by viral hepatitis infections. Disease burden is not defined in Queensland, particularly for Indigenous, migrant and regional and remote communities. Such factors may influence risk of viral hepatitis, access to treatment, and incidence and survival of HCC. Defining disease burdens will enable clinical programs targeted at groups most at risk in order to impact HCC trends.Read moreRead less
Supporting Informed Choice For Management Of Screen Detected Ductal Carcinoma In Situ (DCIS) Among Older Women (70 Years And Over)
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
DCIS refers to abnormal changes in the breast that may or may not lead to breast cancer later on. Screening women over 70 means more DCIS will be found and treated by surgery, radiotherapy, and other treatments. To avoid unnecessary treatment, some DCIS patients could instead have regular checks (monitoring). This research will develop a tool to help women over 70 with DCIS to make an informed choice between monitoring or immediate treatment, and test whether this improves their quality of life.